Talis Biomedical Corp
TLISHealthcare · Healthcare · <br>Emerging growth company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|
| Revenue | $2.1M | $4.8M | $8.2M | — |
| Operating income | −$66.8M | −$115.1M | −$191.8M | −$91.2M |
| Net income | −$62.0M | −$113.0M | −$192.0M | −$91.1M |
| Total assets | $94.7M | $169.3M | $265.8M | $198.4M |
| Total liabilities | $25.6M | $42.6M | $31.9M | $16.0M |
| Equity | $69.1M | $126.7M | $234.0M | −$108.6M |
| EPS (diluted) | $-34.12 | $-62.77 | $-8.48 | — |
| Shares out. | 56.7M | 56.6M | 26.4M | 2.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −3131.0%
- Net margin
- −2905.7%
- Return on equity
- −89.7%
- Return on assets
- −65.5%
- Return on capital (ROCE)
- −77.8%
- Liabilities / assets
- 27.0%
- Debt / equity
- 0.37×
- Book value / share
- $1.22
- Revenue growth (YoY)
- −55.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -15.72distress
- Accruals / assets
- −9.3%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Leonard Braden Michael10% owner | Sep 5, 2024 | Buy | 5,100 | $1.40 |
| Leonard Braden Michael10% owner | Sep 3, 2024 | Buy | 500 | $4.00 |
| Leonard Braden Michael10% owner | Aug 30, 2024 | Buy | 151 | $4.25 |
| Leonard Braden Michael10% owner | Aug 26, 2024 | Buy | 13,167 | $3.90 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Dec 15, 2025 | 4,113 | 4.9 | 0.0% |
| Nov 28, 2025 | 4,113 | 6.5 | 0.0% |
| Nov 14, 2025 | 4,113 | 4.8 | 0.0% |
| Oct 31, 2025 | 4,113 | 4.6 | -23.2% |
| Oct 15, 2025 | 5,354 | 140.9 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementSep 17, 2024
- Entered a material agreementSep 6, 2024
- Entered a material agreementSep 3, 2024
- Delisting / listing-standard noticeAug 23, 2024
- Director / officer changeAug 6, 2024
- Entered a material agreementJun 25, 2024
- Entered a material agreementJun 3, 2024
- Entered a material agreementMay 3, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.